• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 3. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

Introduction to 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid (CAS No. 1360950-40-8)

2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid, with the CAS number 1360950-40-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrimidine class, which is a heterocyclic aromatic organic compound comprising nitrogen, carbon, and hydrogen. Pyrimidines are fundamental structural units in nucleic acids, where they pair with purines to form the base pairs of DNA and RNA. Beyond their biological significance, pyrimidine derivatives have been extensively explored for their pharmacological properties, making them valuable scaffolds in drug discovery and development.

The structure of 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid features a pyrimidine core substituted with two Boc (tert-butoxycarbonyl) protected amino groups at the 2-position and a boronic acid moiety at the 5-position. The Boc protection is a common strategy in peptide synthesis and medicinal chemistry to prevent unwanted side reactions, ensuring the stability and reactivity of the compound during further derivatization. The boronic acid group is particularly noteworthy as it serves as a key functional handle for Suzuki-Miyaura cross-coupling reactions, a widely used palladium-catalyzed reaction in organic synthesis that enables the formation of carbon-carbon bonds. This reaction is instrumental in constructing complex molecular architectures, making 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid a versatile intermediate in synthetic chemistry.

In recent years, there has been growing interest in pyrimidine-based compounds due to their broad spectrum of biological activities. These activities include antiviral, anticancer, anti-inflammatory, and antimicrobial properties. The introduction of substituents such as amino groups and boronic acids enhances the pharmacological potential of pyrimidine derivatives by modulating their interactions with biological targets. For instance, amino groups can participate in hydrogen bonding interactions with proteins or act as anchors for further functionalization, while boronic acids can engage with enzymes or receptors in unique ways.

One of the most compelling applications of 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid is in the development of novel therapeutic agents. The boronic acid functionality allows for facile coupling with aryl halides or other boronic acids via Suzuki-Miyaura cross-coupling, enabling the construction of complex drug candidates. This method has been particularly successful in the design of kinase inhibitors, which are critical in targeted cancer therapies. Kinases are enzymes that play a central role in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By developing selective kinase inhibitors, researchers aim to disrupt aberrant signaling pathways and restore normal cellular function.

Recent studies have highlighted the potential of 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid as a precursor in the synthesis of small-molecule inhibitors targeting specific kinases. For example, modifications to the pyrimidine core have been shown to enhance binding affinity and selectivity towards particular kinase isoforms. Such selectivity is crucial for minimizing side effects and improving therapeutic efficacy. Additionally, computational modeling and high-throughput screening techniques have been employed to identify optimal substitution patterns on the pyrimidine ring that enhance bioactivity.

The pharmaceutical industry has also leveraged 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid in the development of antiviral drugs. Pyrimidine derivatives have demonstrated efficacy against various viruses by inhibiting viral replication or modulating host immune responses. The Boc-protected amino groups provide stability during synthetic transformations while allowing for controlled deprotection under specific conditions to reveal active pharmacophores. This balance between stability and reactivity makes 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid an invaluable building block in antiviral drug design.

Moreover, advances in medicinal chemistry have enabled the exploration of 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid for applications beyond traditional small-molecule drug development. For instance, its use as a chiral building block has been investigated in asymmetric synthesis, where enantiomerically pure compounds are synthesized to enhance pharmacological potency and reduce toxicity. The boronic acid group also facilitates conjugation with biomolecules such as peptides and proteins through click chemistry approaches, expanding its utility in biopharmaceutical applications.

The synthetic versatility of 2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid extends to its incorporation into libraries of compounds for high-throughput screening (HTS). HTS platforms allow researchers to rapidly test thousands of compounds against biological targets to identify lead candidates for further optimization. The ability to efficiently synthesize and modify pyrimidine derivatives like this compound has accelerated drug discovery pipelines significantly over recent decades.

In conclusion,2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid (CAS No. 1360950-40-8) represents a promising intermediate in pharmaceutical chemistry with diverse applications across drug development pipelines. Its unique structural features—combining protective Boc groups with reactive boronic acids—make it an exceptionally versatile building block for synthesizing biologically active molecules targeting various diseases. As research continues to uncover new therapeutic opportunities derived from pyrimidine scaffolds,2-(N,N-Bis-Boc-amino)pyrimidine-5-boronic acid is poised to remain at forefront of medicinal chemistry innovation.

• 1190423-36-9(tert-butyl N-[(tert-butoxy)carbonyl]-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]carbamate)
• 1448461-87-7([2-(4-tert-butoxycarbonylpiperazin-1-yl)pyrimidin-5-yl]boronic acid)
• 883231-25-2((2-((Tert-Butoxycarbonyl)amino)pyrimidin-5-yl)boronic acid)
• 264600-82-0(2-(di-(t-butoxycarbonyl)amino)pyrimidine)
• 1033744-52-3(2-(tert-butoxycarbonyl(methyl)amino)pyrimidin-5-ylboronic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)